Outcomes for COPD pharmacological trials:: from lung function to biomarkers

被引:650
作者
Cazzola, M. [1 ]
MacNee, W. [5 ]
Martinez, F. J. [16 ]
Rabe, K. F. [21 ]
Franciosi, L. G. [6 ]
Barnes, P. J. [7 ]
Brusasco, V. [3 ]
Burge, P. S. [11 ]
Calverley, P. M. A. [15 ]
Celli, B. R. [17 ]
Jones, P. W. [8 ]
Mahler, D. A. [18 ]
Make, B. [19 ]
Miravitlles, M. [24 ]
Page, C. P. [9 ]
Palange, P. [2 ]
Parr, D. [13 ,14 ]
Pistolesi, M. [4 ]
Rennard, S. I.
Moelken, M. P. Rutten-Van [22 ]
Stockley, R. [12 ]
Sullivan, S. D. [20 ]
Wedzicha, J. A. [10 ]
Wouters, E. F. [23 ]
机构
[1] Univ Roma Tor Vergata, Unit Resp Dis, Dept Internal Med, I-00133 Rome, Italy
[2] Univ Roma La Sapienza, Rome, Italy
[3] Univ Genoa, Genoa, Italy
[4] Univ Florence, I-50121 Florence, Italy
[5] Colt Res Labs, Sch Med, Edinburgh, Midlothian, Scotland
[6] Kings Coll London, London, England
[7] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England
[8] Univ London, St Georges Hosp, London WC1E 7HU, England
[9] Kings Coll Hosp London, Sch Med, Sackler Inst Pulm Pharmacol, London, England
[10] UCL, London WC1E 6BT, England
[11] Birmingham Heartlands Hosp, Birmingham, W Midlands, England
[12] Queen Elizabeth Hosp, Birmingham, W Midlands, England
[13] Univ Hosp Covertry, Coventry, W Midlands, England
[14] Univ Hosp Warcickshire, Coventry, W Midlands, England
[15] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
[16] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA
[17] Caritas St Elizabeth Med Ctr, Boston, MA USA
[18] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[19] Natl Jewish Med & Res Ctr, Denver, CO USA
[20] Univ Washington, Seattle, WA 98195 USA
[21] Leiden Univ, Med Ctr, Leiden, Netherlands
[22] Erasmus MC Univ, Med Ctr Rotterdam, Rotterdam, Netherlands
[23] Univ Hosp Maastricht, Maastricht, Netherlands
[24] Hosp Clin Barcelona, Barcelona, Spain
关键词
D O I
10.1183/09031936.00099306
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The American Thoracic Society/European Respiratory Society jointly created a Task Force on "Outcomes for COPD pharmacological trials: from lung function to biomarkers" to inform the chronic obstructive pulmonary disease research community about the possible use and limitations of current outcomes and markers when evaluating the impact of a pharmacological therapy. Based on their review of the published literature, the following document has been prepared with individual sections that address specific outcomes and markers, and a final section that summarises their recommendations.
引用
收藏
页码:416 / 468
页数:53
相关论文
共 582 条
[71]   Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD [J].
Brusasco, V ;
Hodder, R ;
Miravitlles, M ;
Korducki, L ;
Towse, L ;
Kesten, S .
THORAX, 2003, 58 (05) :399-404
[72]   High levels of interleukin-6 in the exhaled breath condensate of patients with COPD [J].
Bucchioni, E ;
Kharitonov, SA ;
Allegra, L ;
Barnes, PJ .
RESPIRATORY MEDICINE, 2003, 97 (12) :1299-1302
[73]   Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial [J].
Burge, PS ;
Calverley, PMA ;
Jones, PW ;
Spencer, S ;
Anderson, JA ;
Maslen, TK .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7245) :1297-1303
[74]   COURSE AND PROGNOSIS OF CHRONIC OBSTRUCTIVE LUNG DISEASE - A PROSPECTIVE STUDY OF 200 PATIENTS [J].
BURROWS, B ;
EARLE, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (08) :397-&
[75]   2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].
BUTLAND, RJA ;
PANG, J ;
GROSS, ER ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608
[76]   Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial [J].
Calverley, P ;
Pauwels, R ;
Vestbo, J ;
Jones, P ;
Pride, N ;
Gulsvik, A ;
Anderson, J ;
Maden, C .
LANCET, 2003, 361 (9356) :449-456
[77]  
Calverley Peter M A, 2005, COPD, V2, P143
[78]   Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease [J].
Calverley, PM ;
Boonsawat, W ;
Cseke, Z ;
Zhong, N ;
Peterson, S ;
Olsson, H .
EUROPEAN RESPIRATORY JOURNAL, 2003, 22 (06) :912-919
[79]   Bronchodilator reversibility testing in chronic obstructive pulmonary disease [J].
Calverley, PMA ;
Burge, PS ;
Spencer, S ;
Anderson, JA ;
Jones, PW .
THORAX, 2003, 58 (08) :659-664
[80]  
CAMERON JR, 1991, PHYS SOC NEWS, V20, P2